{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:00:12Z","timestamp":1780909212853,"version":"3.54.1"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Despite several studies reporting the effectiveness of dapsone in immune thrombocytopenic purpura (ITP), information on its mechanism of action, dose\u2013response relationship and response predictors remains limited. To address this knowledge gap, we analysed 433 healthcare visit data of 58 ITP patients (29 males and 29 females; 39 adults and 19 paediatric) treated with dapsone (mean: 1.19\u2009mg\/kg\/day) after 0\u20134 prior treatments. Among them, 14 had newly diagnosed, 23 had persistent and 21 had chronic ITP. The median ages for paediatric and adult patients were 6.4 and 40.9\u2009years respectively. Median response time, response duration and follow\u2010up period were 40, 151 and 142\u2009days respectively. The overall response rate was 58.6%, of which 94.1% of patients responded within 6\u2009months and 44.8% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200926) maintained a response at the last follow\u2010up. Mediation analysis showed that the association between dapsone and responses was mediated via haemoglobin reduction. Response rates were 5.38 times higher in patients who experienced a reduction in haemoglobin than in those who did not experience a reduction in haemoglobin (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008). Age, sex, previous treatment numbers and response, ITP types, baseline platelets and concurrent treatments were not associated with a response. Two patients needed dapsone discontinuation due to adverse events.\n                  <\/jats:p>","DOI":"10.1111\/bjh.70414","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:10:28Z","timestamp":1773105028000},"page":"1768-1776","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dapsone response in immune thrombocytopenic purpura is associated with dapsone dose and mediated through reduction in haemoglobin: A longitudinal data analysis of 58 adult and paediatric\n                    <scp>ITP<\/scp>\n                    patients demonstrates efficacy and safety"],"prefix":"10.1111","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3062-7191","authenticated-orcid":false,"given":"Shaan D.","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Medicine B.J. Medical College  Ahmedabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0184-2553","authenticated-orcid":false,"given":"Aarti","family":"Vibhakar","sequence":"additional","affiliation":[{"name":"Haematology Clinic  Ahmedabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi P.","family":"Shah","sequence":"additional","affiliation":[{"name":"Haematology Clinic  Ahmedabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Rathod","sequence":"additional","affiliation":[{"name":"Department of Physiology Narendra Modi Medical College  Ahmedabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurang","family":"Modi","sequence":"additional","affiliation":[{"name":"Oncowin Cancer Center  Ahmedabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0075-3304","authenticated-orcid":false,"given":"Ashwin","family":"Patel","sequence":"additional","affiliation":[{"name":"Haematology Clinic  Ahmedabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010968"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00545.x"},{"key":"e_1_2_12_4_1","first-page":"421","article-title":"Dapsone in treatment of chronic idiopathic thrombocytopenic purpura in adults","volume":"49","author":"Dutta TK","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/09537100802315110"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.412687.x"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15396"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1064.1064"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V108.11.1073.1073"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12371"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01286-9"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187296"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012541"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000492187"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05179.x"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200302000-00019"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830440117"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-162503"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1589"},{"key":"e_1_2_12_22_1","unstructured":"World Health Organization.WHO handbook for reporting results of cancer treatment.1979. Available from:https:\/\/iris.who.int\/handle\/10665\/37200"},{"key":"e_1_2_12_23_1","unstructured":"Dep. of Health & Human Services.Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.2017. Available from:https:\/\/dctd.cancer.gov\/research\/ctep\u2010trials\/for\u2010sites\/adverse\u2010events\/ctcae\u2010v5\u20108x11.pdf"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2022.07.005"},{"issue":"3","key":"e_1_2_12_25_1","first-page":"205","article-title":"Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases","volume":"76","author":"Schmidt E","year":"2005","journal-title":"Cutis"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.47276\/lr.94.2.124"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08594-X"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.51.6.1173"},{"key":"e_1_2_12_29_1","unstructured":"Rheumatologic Dermatology Society.Dapsone. Available from:https:\/\/www.rheumaderm\u2010society.org\/dapsone\/#:~:text=Dapsone%20can%20cause%20a%20rash%20that%20is%20usually and%20liver%20changes%20that%20require%20stopping%20the%20dapsone"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014939"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3259.ijct20232191"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-020-00703-7"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2014.886677"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19277"},{"issue":"3","key":"e_1_2_12_35_1","article-title":"Dapsone as a cheap and safe second\u2010line drug for chronic immune thrombocytopenia in developing countries: a prospective cohort study","volume":"5","author":"Khan YB","year":"2014","journal-title":"J Appl Hematol"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12792"},{"key":"e_1_2_12_37_1","unstructured":"TATA 1 mg India.2025. Available from:https:\/\/www.1mg.com\/?srsltid=AfmBOoougRj5LIitkdbHiGTSJZPvELMoo4jYmi6jww_9oEMeuet49uOE&wpsrc=Google+Organic+Search"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2015.08.007"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.12914"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201700090"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2014.49.3.187"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70414","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.70414","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:10:25Z","timestamp":1780906225000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/bjh.70414"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70414","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"2025-08-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}